How to Talk When a Machine Is Listening: Corporate Disclosure in the Age of AI
The Review of Financial Studies · 21.08.2023 · 36 (9) · 3603-3642
DOI: 10.1093/rfs/hhad021 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Financial Studies, online erschienen am 27.03.2023. Verfasst von Sean Cao und 3 weiteren Autor:innen. Die Arbeit wurde bisher 233-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Growing AI readership (proxied for by machine downloads and ownership by AI-equipped investors) motivates firms to prepare filings friendlier to machine processing and to mitigate linguistic tones that are unfavorably perceived by algorithms. Loughran and McDonald (2011) and BERT available since 2018 serve as event studies supporting attribution of the decrease in the measured negative sentiment to increased machine readership. This relationship is stronger among firms with higher benefits to (e.g., external financing needs) or lower cost (e.g., litigation risk) of sentiment management. This is the first study exploring the feedback effect on corporate disclosure in response to technology. Authors have furnished an Internet Appendix, which is available on the Oxford University Press Web site next to the link to the final published paper online.
Zitieren
APA
Cao, S., Jiang, W., Yang, B., & Zhang, A. L. (2023). How to Talk When a Machine Is Listening: Corporate Disclosure in the Age of AI. The Review of Financial Studies, 36(9), 3603-3642. https://doi.org/10.1093/rfs/hhad021
Vancouver
Cao S, Jiang W, Yang B, Zhang AL. How to Talk When a Machine Is Listening: Corporate Disclosure in the Age of AI. The Review of Financial Studies. 2023;36(9):3603-3642. doi:10.1093/rfs/hhad021
BibTeX
@article{Cao2023,
author = {Cao, Sean and Jiang, Wei and Yang, Baozhong and Zhang, Alan L},
title = {How to Talk When a Machine Is Listening: Corporate Disclosure in the Age of AI},
journal = {The Review of Financial Studies},
year = {2023},
volume = {36},
number = {9},
pages = {3603--3642},
doi = {10.1093/rfs/hhad021}
}
EUVIMED